家禽藥品市場－全球產業規模、佔有率、趨勢、機會和預測（按品種、產品、疾病、配銷通路、地區和競爭細分，2020-2030 年）

2024 年全球家禽藥品市場規模為 67.8 億美元，預計到 2030 年將達到 101 億美元，複合年成長率為 6.84%。隨著家禽業在滿足全球對肉類和蛋類等高蛋白食品日益成長的需求方面繼續發揮關鍵作用，全球家禽藥品市場正在穩步擴張。商業化家禽養殖的成長和獸醫學的進步，對有效的治療和預防解決方案的需求強勁。對改善動物健康管理的需求，加上禽流感、新城疫和球蟲病等家禽相關疾病的盛行率上升，進一步推動了市場的發展。為了保持雞群生產力並最大限度地降低死亡率，疫苗、藥物和飼料添加劑的使用日益增多，這鼓勵了人們對這一領域的更多投資。消費者對高品質家禽產品的強烈偏好也導致人們更加關注生物安全和先進的醫療保健實踐，從而刺激了家禽藥品的發展。

主要成長動力之一是已開發國家和發展中國家禽肉消費量的激增，這得益於禽肉價格實惠且營養豐富。這種消費成長給家禽生產者帶來了維持禽群健康的巨大壓力，從而催生了對預防和治療藥物的需求。由於對抗生素抗藥性的擔憂，一個影響市場發展的突出趨勢是，人們擴大轉向抗生素的替代解決方案，例如益生菌、植物性添加劑和疫苗。診斷技術和精準獸醫學的進步也使得早期疾病檢測和針對性治療成為可能，從而提高了家禽健康管理的效率。另一個日益成長的趨勢是採用綜合健康管理方案，將疫苗接種、營養補充劑和衛生規範相結合，以提高家禽生產力並減少損失。

儘管成長前景強勁，但市場仍面臨挑戰，這可能會在預測期內限制其潛力。先進家禽藥品和疫苗的高成本仍然是一個障礙，尤其對於價格敏感型經濟體的中小型養殖戶而言。有關獸藥（尤其是抗生素）核准和使用的嚴格監管框架也給製造商帶來了合規挑戰。人們對抗生素抗藥性的擔憂日益加劇，促使監管更加嚴格，這可能會影響某些常規藥物的採用。此外，在可負擔性和創新性之間保持平衡仍然是行業利益相關者面臨的關鍵挑戰。確保有效家禽藥品的廣泛可及性，同時解決環境和食品安全問題，對於維持全球家禽藥品市場的長期成長仍然至關重要。

關鍵市場促進因素

禽肉和蛋類消費量上升

主要市場挑戰

先進獸藥價格高昂

主要市場趨勢

向無抗生素家禽生產轉變

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球家禽藥品市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依種類（雞、土耳其、鴨、其他）
  • 依產品（生物製劑、藥品、藥物飼料添加劑）
  • 依疾病（新城疫、傳染性支氣管炎、傳染性法氏囊病、球蟲病、沙門氏菌病、馬立克氏病、其他）
  • 依配銷通路（獸醫院及診所、電子商務、線下零售店、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第6章：北美家禽藥品市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲家禽藥品市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太家禽藥品市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲家禽藥品市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲家禽藥品市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Vaxxinova International BV
• Merck & Co., Inc.
• Calier SA
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Kemin Industries, Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

Global Poultry Medicine Market was valued at USD 6.78 Billion in 2024 and is expected to reach USD 10.10 Billion by 2030 with a CAGR of 6.84%. The Global Poultry Medicine Market is witnessing steady expansion as the poultry industry continues to play a critical role in meeting the rising global demand for protein-rich food products such as meat and eggs. Growth in commercial poultry farming and advancements in veterinary medicine are creating strong demand for effective treatment and preventive solutions. The need for improved animal health management, coupled with the rising prevalence of poultry-related diseases such as avian influenza, Newcastle disease, and coccidiosis, is further boosting the market. Increasing adoption of vaccines, pharmaceuticals, and feed additives to maintain flock productivity and minimize mortality rates is encouraging greater investments in this segment. Strong consumer preference for high-quality poultry products is also leading to heightened focus on biosecurity and advanced healthcare practices, stimulating the growth of poultry medicine.

One of the major growth drivers is the surge in poultry meat consumption across both developed and developing nations, driven by its affordability and nutritional benefits. This rising consumption places significant pressure on poultry producers to maintain flock health, thus generating demand for preventive and therapeutic medicines. A prominent trend shaping the market is the increasing shift toward alternative solutions to antibiotics, such as probiotics, phytogenic additives, and vaccines, due to concerns around antimicrobial resistance. Technological advancements in diagnostics and precision veterinary medicine are also enabling early disease detection and targeted treatment, enhancing efficiency in poultry health management. Another trend gaining momentum is the adoption of integrated health management programs that combine vaccination, nutritional supplements, and hygiene practices to improve poultry productivity and reduce losses.

Despite strong growth prospects, the market faces challenges that could restrain its potential during the forecast period. High costs associated with advanced poultry medicines and vaccines remain a barrier, especially for small and medium-scale farmers in price-sensitive economies. Stringent regulatory frameworks concerning the approval and use of veterinary medicines, particularly antibiotics, also present compliance challenges for manufacturers. Rising concerns over antimicrobial resistance are prompting stricter controls, which may impact the adoption of certain conventional medicines. Moreover, maintaining the balance between affordability and innovation continues to be a key challenge for industry stakeholders. Ensuring widespread accessibility of effective poultry medicines while addressing environmental and food safety concerns will remain critical for sustaining long-term growth in the Global Poultry Medicine Market.

Key Market Drivers

Rising Poultry Meat and Egg Consumption

Rising poultry meat and egg consumption is a pivotal driver in the Global Poultry Medicine Market, as growing demand directly influences the adoption of advanced healthcare solutions for flocks. Poultry has become the most affordable and accessible source of animal protein, widely consumed due to its favorable nutritional profile, quick production cycle, and versatility in diets. Government statistics highlight the strength of this trend. In India, total egg production rose to 142.77 billion eggs in FY 2023-24, representing a 3.18% increase over the previous year, while poultry meat output reached 10.25 million tonnes, up by nearly 5% according to official data released by the Department of Animal Husbandry and Dairying. Per capita availability of eggs in India stood at 103 eggs per annum, which remains below the National Institute of Nutrition's recommendation, suggesting considerable growth potential in consumption.

Globally, the FAO-OECD Agricultural Outlook 2025-2034 projects poultry meat consumption to rise to 173 million tonnes (ready-to-cook basis) by 2034, accounting for about 62% of the total additional meat consumed worldwide. This growth reflects shifting dietary patterns as consumers in both developed and developing countries favor poultry over red meats due to affordability and health perceptions. In the United States, USDA data shows poultry remains a core component of the national diet, with per capita consumption consistently higher than beef and pork, reflecting strong cultural and nutritional preferences.

This steady rise in poultry meat and egg consumption underscores the need for effective disease prevention and treatment strategies. Producers must manage infectious risks while ensuring flock productivity and food safety. The growing reliance on veterinary medicines such as vaccines, biologics, and feed-based solutions is directly tied to this consumption boom, making rising demand for poultry products a crucial long-term growth driver for the market.

Key Market Challenges

High Cost of Advanced Veterinary Medicines

The high cost of advanced veterinary medicines represents one of the most significant challenges for the Global Poultry Medicine Market, particularly in regions where poultry farming is driven by small and medium-scale producers. Modern pharmaceuticals, biologics, and next-generation vaccines often involve extensive research, development, and regulatory approval processes, which substantially increase their market price. For commercial farms with large-scale operations, these costs may be manageable due to higher revenue streams, but for smaller producers, the financial burden becomes a barrier to adoption. Limited access to cost-effective alternatives leaves many farmers reliant on traditional or less effective solutions, increasing the risk of disease outbreaks, higher mortality, and reduced productivity.

The financial constraints also limit the ability of farmers to implement preventive healthcare programs, as they often prioritize immediate cost savings over long-term benefits. This creates a cycle were inadequate investment in quality medicines results in higher vulnerability to disease, leading to economic losses that could have been avoided with advanced treatments. The disparity in affordability also impacts market penetration for veterinary pharmaceutical companies, as demand for innovative products is concentrated in developed economies while adoption in emerging markets remains limited. Balancing innovation with affordability is a pressing challenge, as manufacturers must continue to invest in developing novel solutions to address issues like antimicrobial resistance and emerging poultry diseases, while ensuring that their products remain accessible to producers in price-sensitive regions. Without cost-effective strategies such as tiered pricing models, local manufacturing partnerships, or government-supported subsidies, the high cost of advanced veterinary medicines may slow down the widespread adoption of innovative healthcare practices in poultry farming, ultimately restricting the market's long-term growth potential.

Key Market Trends

Shift Toward Antibiotic-Free Poultry Production

The Global Poultry Medicine Market is experiencing a significant transformation driven by the industry-wide shift toward antibiotic-free poultry production. Growing concerns about antimicrobial resistance (AMR) and the presence of antibiotic residues in meat and eggs have prompted regulators, consumers, and producers to rethink their approach to poultry health management. Consumers are increasingly demanding clean-label, residue-free poultry products, compelling producers to seek alternatives that maintain bird health without compromising food safety. Governments across several regions have introduced stricter policies restricting the use of growth-promoting antibiotics in poultry farming, creating a strong push toward sustainable and responsible practices. This shift has created rising demand for probiotic formulations, phytogenic feed additives, vaccines, and herbal medicines, which offer effective disease prevention and immunity enhancement while aligning with consumer preferences.

Producers are also investing in improved biosecurity measures, nutritional optimization, and flock management strategies to reduce reliance on antibiotics. The market is witnessing increased innovation in natural and biologic-based solutions that address respiratory, digestive, and immunological challenges without contributing to AMR. Veterinary pharmaceutical companies are expanding research collaborations to develop next-generation alternatives that can be scaled effectively for commercial poultry operations. The trend toward antibiotic-free production is not only reshaping product portfolios but is also emerging as a competitive differentiator in the global poultry industry.

Key Market Players

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Vaxxinova International BV
• Merck & Co., Inc.
• Calier S.A.
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Kemin Industries, Inc.

Report Scope:

In this report, the Global Poultry Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Medicine Market, By Species:

• Chicken
• Turkey
• Ducks
• Others

Poultry Medicine Market, By Product:

• Biologics
• Pharmaceuticals
• Medicated Feed Additives

Poultry Medicine Market, By Disease:

• Newcastle Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Coccidiosis
• Salmonella
• Marek's Disease
• Others

Poultry Medicine Market, By Distribution Channel:

• Veterinary Hospitals & Clinics
• E-commerce
• Offline Retail Stores
• Others

Poultry Medicine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Poultry Medicine Market.

Available Customizations:

Global Poultry Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Poultry Medicine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Species (Chicken, Turkey, Ducks, Others)
  • 5.2.2. By Product (Biologics, Pharmaceuticals, Medicated Feed Additives)
  • 5.2.3. By Disease (Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease, Coccidiosis, Salmonella, Marek's Disease, Others)
  • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Offline Retail Stores, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Poultry Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Species
  • 6.2.2. By Product
  • 6.2.3. By Disease
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Poultry Medicine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Species
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Disease
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Mexico Poultry Medicine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Species
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Disease
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Canada Poultry Medicine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Species
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Disease
      • 6.3.3.2.4. By Distribution Channel

7. Europe Poultry Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Species
  • 7.2.2. By Product
  • 7.2.3. By Disease
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Poultry Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Species
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Disease
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. Germany Poultry Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Species
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Disease
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Poultry Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Species
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Disease
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Poultry Medicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Species
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Disease
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Poultry Medicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Species
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Disease
      • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Poultry Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Species
  • 8.2.2. By Product
  • 8.2.3. By Disease
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Poultry Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Species
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Disease
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Poultry Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Species
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Disease
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. South Korea Poultry Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Species
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Disease
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. Japan Poultry Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Species
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Disease
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Poultry Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Species
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Disease
      • 8.3.5.2.4. By Distribution Channel

9. South America Poultry Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Species
  • 9.2.2. By Product
  • 9.2.3. By Disease
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Poultry Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Species
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Disease
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. Argentina Poultry Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Species
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Disease
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. Colombia Poultry Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Species
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Disease
      • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Poultry Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Species
  • 10.2.2. By Product
  • 10.2.3. By Disease
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Poultry Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Species
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Disease
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Saudi Arabia Poultry Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Species
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Disease
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. UAE Poultry Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Species
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Disease
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Zoetis Services LLC
• 15.3. Vaxxinova International BV
• 15.4. Merck & Co., Inc.
• 15.5. Calier S.A.
• 15.6. Elanco Animal Health Incorporated
• 15.7. Hester Biosciences Limited
• 15.8. Ceva Sante Animale
• 15.9. Phibro Animal Health Corporation
• 15.10. Kemin Industries, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer